Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Arthur Frederick RyanIndependent Director | -100,00 | 70,52k | Verkauf | 701,76 - 714,13 | 15,80k | -0,63% |
| 2026-04-01 | Mr. Arthur Frederick RyanIndependent Director | -100,00 | 77,73k | Automatic Disposition | 771,32 - 779,71 | 15,90k | -0,63% |
| 2026-03-02 | Mr. Arthur Frederick RyanIndependent Director | -100,00 | 78,55k | Automatic Disposition | 777,46 - 789,28 | 16,00k | -0,62% |
| 2026-02-19 | Dr. Huda Y. ZoghbiIndependent Director | -1,64k | 662,79k | Derivative Exercise and Sale | 376,69 - 790,00 | 0,00 | - |
| 2026-02-09 | Mr. Jason PitofskySenior VP & Controller | -1.000,00 | 284,97k | Derivative Exercise and Sale | 492,00 - 778,35 | 4,48k | - |
| 2026-02-09 | Mr. Jason PitofskySenior VP & Controller | -1,04k | 808,08k | Automatic Disposition | 778,35 - 785,72 | 4,48k | -18,77% |
| 2026-02-09 | Mr. Arthur Frederick RyanIndependent Director | -100,00 | 77,85k | Automatic Disposition | 775,63 - 787,82 | 16,10k | -0,62% |
| 2026-01-07 | Dr. Bonnie L. BasslerIndependent Director | -1,50k | 638,82k | Derivative Exercise and Sale | 374,12 - 800,00 | 0,00 | - |
| 2025-12-31 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | -28,57k | 22,06M | Derivative Exercise and Sale | 772,09 | 1,13M | - |
| 2025-12-31 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | -28,57k | 22,06M | Derivative Exercise and Sale | 772,09 | 687,98k | - |
| 2025-12-30 | Mr. George L. SingIndependent Director | 3,02k | 1,57M | Derivative Exercise and Retained Stock | 520,01 | 33,00k | 10,09% |
| 2025-12-30 | Mr. George L. SingIndependent Director | -6,19k | 1,57M | Derivative Exercise and Sale | 520,01 - 774,03 | 33,00k | - |
| 2025-12-09 | Mr. Daniel P. Van PlewExec. VP and GM of Industrial Operations & Product Supply | -2,55k | 1,79M | Sale to Issuer | 701,51 | 35,18k | -6,76% |
| 2025-12-09 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -4,23k | 2,97M | Sale to Issuer | 701,51 | 52,21k | -7,49% |
| 2025-12-09 | Ms. Marion E. McCourtExec. VP of Commercial | -1,02k | 716,24k | Sale to Issuer | 701,51 | 14,55k | -6,56% |
| 2025-12-09 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | 14,94k | 8,30M | Derivative Exercise and Retained Stock | 555,67 | 1,13M | 1,34% |
| 2025-12-09 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | -131,87k | 19,23M | Derivative Exercise and Sale | 555,67 - 701,51 | 1,13M | - |
| 2025-12-09 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | 17,58k | 9,77M | Derivative Exercise and Retained Stock | 555,67 | 687,98k | 2,62% |
| 2025-12-09 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | -155,15k | 22,63M | Derivative Exercise and Sale | 555,67 - 701,51 | 687,98k | - |
| 2025-12-08 | Mr. Jason PitofskySenior VP & Controller | -989,00 | 705,10k | Sale to Issuer | 712,94 | 5,52k | -15,20% |
| 2025-12-08 | Mr. Daniel P. Van PlewExec. VP and GM of Industrial Operations & Product Supply | -1,91k | 1,36M | Sale to Issuer | 712,94 | 37,73k | -4,81% |
| 2025-12-08 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -1,70k | 1,21M | Sale to Issuer | 712,94 | 56,44k | -2,92% |
| 2025-12-08 | Ms. Marion E. McCourtExec. VP of Commercial | -1,34k | 952,49k | Sale to Issuer | 712,94 | 15,57k | -7,90% |
| 2025-12-08 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | -1,40k | 995,26k | Sale to Issuer | 712,94 | 42,32k | -3,19% |
| 2025-12-08 | Mr. Christopher R. FenimoreExec. VP of Finance & CFO | -992,00 | 707,24k | Sale to Issuer | 712,94 | 21,80k | -4,35% |
| 2025-11-20 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | 1,76k | 980,20k | Derivative Exercise and Retained Stock | 555,67 | 41,23k | 4,47% |
| 2025-11-20 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | -12,69k | 2,30M | Derivative Exercise and Sale | 555,67 - 736,77 | 41,23k | - |
| 2025-11-20 | Dr. Bonnie L. BasslerIndependent Director | -760,00 | 287,74k | Derivative Exercise and Sale | 371,40 - 750,00 | 0,00 | - |
| 2025-11-07 | Mr. Jason PitofskySenior VP & Controller | -431,00 | 280,77k | Verkauf | 651,43 | 4,44k | -8,84% |
| 2025-10-30 | Ms. Christine Ann PoonLead Independent Director | 2,71k | 1,41M | Derivative Exercise and Retained Stock | 520,01 | 3,52k | 337,31% |
| 2025-10-29 | Ms. Christine Ann PoonLead Independent Director | -6,50k | 872,68k | Derivative Exercise and Sale | 520,01 - 657,29 | 3,52k | - |
| 2025-10-29 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | 972,00 | 540,11k | Derivative Exercise and Retained Stock | 555,67 | 54,42k | 1,82% |
| 2025-10-29 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -34,03k | 2,17M | Derivative Exercise and Sale | 555,67 - 648,82 | 54,42k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
